Feedback / Questions
ERAS-601 - Erasca
Erbitux (cetuximab) - Eli Lilly
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT04670679
Sep 17, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next